Loading clinical trials...
Loading clinical trials...
A Randomized, Parallel Group Study to Evaluate the Effect of Umeclidinium (UMEC) Added to Inhaled Corticosteroid/ Long-acting Beta-agonist Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease COPD
Conditions
Interventions
UMEC DPI
Placebo DPI
+2 more
Locations
28
Czechia
GSK Investigational Site
Kuřim, Czechia
GSK Investigational Site
Olomouc, Czechia
GSK Investigational Site
Rokycany, Czechia
GSK Investigational Site
Teplice, Czechia
GSK Investigational Site
Žatec, Czechia
GSK Investigational Site
Dillingen an der Donau, Bavaria, Germany
Start Date
September 30, 2014
Primary Completion Date
March 24, 2015
Completion Date
March 24, 2015
Last Updated
August 17, 2017
NCT06831994
NCT02755974
NCT05050591
NCT05913765
NCT05592847
NCT00683722
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions